No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs556151968 |
chr2:234507366-234507367 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs184026545 |
chr2:234507405-234507406 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs34764838 |
chr2:234507414-234507415 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs541614124 |
chr2:234507448-234507449 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs10188008 |
chr2:234507483-234507484 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs562211839 |
chr2:234507496-234507497 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs147041951 |
chr2:234507502-234507503 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs571226259 |
chr2:234507514-234507515 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs74565586 |
chr2:234507515-234507516 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs541471486 |
chr2:234507535-234507536 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs553259727 |
chr2:234507547-234507548 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs573171378 |
chr2:234507577-234507578 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs533139272 |
chr2:234507584-234507585 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs538675228 |
chr2:234507623-234507624 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs550457854 |
chr2:234507634-234507635 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs563781916 |
chr2:234507732-234507733 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs568527799 |
chr2:234507755-234507756 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs113793886 |
chr2:234507785-234507786 |
Enhancers Flanking Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs189808520 |
chr2:234507801-234507802 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs549154643 |
chr2:234507818-234507819 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs558593390 |
chr2:234507819-234507820 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs28967000 |
chr2:234507868-234507869 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs533617026 |
chr2:234507869-234507870 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs193201827 |
chr2:234507927-234507928 |
Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs28967001 |
chr2:234507929-234507930 |
Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs539024831 |
chr2:234507976-234507977 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs185520168 |
chr2:234508000-234508001 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs556426923 |
chr2:234508047-234508048 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs190784266 |
chr2:234508054-234508055 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs180793510 |
chr2:234508070-234508071 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs2602385 |
chr2:234508075-234508076 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs572241690 |
chr2:234508126-234508127 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs138530627 |
chr2:234508173-234508174 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs376184531 |
chr2:234508208-234508209 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs1584800 |
chr2:234508211-234508212 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs557929346 |
chr2:234508225-234508226 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs28967002 |
chr2:234508230-234508231 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
38 |
rs202086868 |
chr2:234508251-234508252 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs543447951 |
chr2:234508295-234508296 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs564048827 |
chr2:234508338-234508339 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs185211560 |
chr2:234508421-234508422 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs529542307 |
chr2:234508467-234508468 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs542837923 |
chr2:234508539-234508540 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs112779730 |
chr2:234508556-234508557 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs528630494 |
chr2:234508589-234508590 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs547102060 |
chr2:234508598-234508599 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs570406800 |
chr2:234508627-234508628 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs188355052 |
chr2:234508660-234508661 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs6728792 |
chr2:234508692-234508693 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
50 |
rs544314305 |
chr2:234508728-234508729 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|